Vasovist

Active Ingredient(s): Gadofosveset Trisodium
FDA Approved: * December 22, 2008
Pharm Company: * EPIX PHARMA
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vasovist Overview

Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[3] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:1...

Read more Vasovist Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadofosveset

Recent Vasovist Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gadofosveset Trisodium
  • Injection: 244mg
  • Solution: 2440mg/10ml (244mg/ml), 3660mg/15ml (244mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gadofosveset Trisodium or a similar ingredient: (1 result)